Sofwave Medical
The Regenerative Aesthetics Company
StartupSofwave Medical is a Yokne'am Illit-based startup in the Health Tech & Life Sciences sector, established in 2015. The Regenerative Aesthetics Company. The company has raised a total of $58.4M across 2 funding rounds, currently at the Public stage. Sofwave Medical was founded by Shimon Eckhouse, Ariel Sverdlik, Genady Nahshon. Key investors include XT Venture Capital, Dr. Shimon Eckhouse, Alon MedTech Ventures. The company has 51-200 employees. Core technologies: Simulation & Imaging, Ultrasound.
With $58.4M in total funding, Sofwave Medical is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StagePublic
- ProductReleased
- ModelB2B
- Employees51-200
- HQYokne'am Illit
- DistrictNorth District
- Last Round$50M
- XT Venture CapitalLead
- Dr. Shimon Eckhouse
- Alon MedTech Ventures
Shimon EckhouseCo-founder
Ariel SverdlikCo-founder & CTOGenady NahshonCo-founder , COO & Site Manager
72 articles covered by sources including finance.yahoo.com,
www.funder.co.il,
www.globenewswire.com,
www.prnewswire.co.uk,
www.prnewswire.com.
What does Sofwave Medical do?
Sofwave Medical specializes in non-invasive aesthetic medical solutions to improve skin laxity, provide lifting effects, and enhance muscle toning. Utilizing its proprietary Synchronous Ultrasound Parallel Beam Technology (SUPERB™), the Sofwave product delivers controlled ultrasound energy to the mid-dermal layer, stimulating collagen and elastin production and improving skin appearance with minimal downtime. Clinically validated and supported by multiple broad FDA clearances, Sofwave's technologies offer effective solutions for patients seeking aesthetic enhancements without invasive procedures. The introduction of the Pure Impact add-on module expands Sofwave's product portfolio, offering increased treatment versatility and efficiency to address a broader range of aesthetic concerns. Pure Impact is the world’s first plyometric muscle activation and toning device, emulating complex, compound full-body muscle movements. Sofwave Plus Pure Impact is the ultimate complement to GLP-1 weight loss drugs. As these medications help with weight loss, Sofwave + Pure Impact ensures no muscle loss, increased tone, and decreased overall laxity, providing a comprehensive solution for enhancing physical appearance and health. Backed by strong clinical data and regulatory endorsements, Sofwave Medical represents a significant opportunity for investors in a rapidly growing market segment.
How much funding has Sofwave Medical raised?
Sofwave Medical has raised $58.4M in total funding across 2 rounds. The company is currently at the Public stage. Key investors include XT Venture Capital, Dr. Shimon Eckhouse, Alon MedTech Ventures.
Who founded Sofwave Medical?
Sofwave Medical was founded in 2015 by Shimon Eckhouse (Co-founder), Ariel Sverdlik (Co-founder & CTO), Genady Nahshon (Co-founder , COO & Site Manager).
What sector is Sofwave Medical in?
Sofwave Medical operates in Health Tech & Life Sciences, Medical Devices, Aesthetic Devices, with core technologies in Simulation & Imaging, Ultrasound. Target customers: Healthcare & Life Sciences, Life Sciences, Cosmetics, Healthcare, Providers, Patients.
Where is Sofwave Medical located?
Sofwave Medical is based in Yokneam Illit, Israel, North District. The company also has offices abroad.